SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-000631
Filing Date
2020-01-09
Accepted
2020-01-09 15:57:07
Documents
40
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1119_oramedpharma.htm 10-Q 274510
2 FIRST AMENDMENT, DATED DECEMBER 19, 2019, TO EMPLOYMENT AGREEMENT, ENTERED INTO f10q1119ex10-1_oramed.htm EX-10.1 8879
3 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS f10q1119ex10-2_oramed.htm EX-10.2 117636
4 CERTIFICATION f10q1119ex31-1_oramed.htm EX-31.1 7932
5 CERTIFICATION f10q1119ex31-2_oramed.htm EX-31.2 7825
6 CERTIFICATION f10q1119ex32-1_oramed.htm EX-32.1 3264
7 CERTIFICATION f10q1119ex32-2_oramed.htm EX-32.2 3286
8 GRAPHIC image_001.jpg GRAPHIC 12864
  Complete submission text file 0001213900-20-000631.txt   1963876

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE ormp-20191130.xml EX-101.INS 232490
10 XBRL SCHEMA FILE ormp-20191130.xsd EX-101.SCH 33314
11 XBRL CALCULATION FILE ormp-20191130_cal.xml EX-101.CAL 36244
12 XBRL DEFINITION FILE ormp-20191130_def.xml EX-101.DEF 92097
13 XBRL LABEL FILE ormp-20191130_lab.xml EX-101.LAB 219367
14 XBRL PRESENTATION FILE ormp-20191130_pre.xml EX-101.PRE 146833
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 20518169
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences